Literature DB >> 12450422

Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarray.

Gina G Chung1, Eric P Kielhorn, David L Rimm.   

Abstract

Immunohistochemistry is a useful technique to localize antigens in cell preparations and tissue sections and can be helpful in identifying molecular markers that may be predictive of patient outcomes. Subjective assessment of expression and semiquantitative grading systems are the current standards in pathology literature for the analysis of tissue sections. However, expression levels assessed in this manner may be dramatically affected by the method of visualization. Tissue microarray (TMA) is a recently developed technique for the simultaneous high-throughput evaluation of protein expression on tissue samples from large cohorts of patients. The scoring of TMAs has, in general, mirrored the systems utilized for tissue sections. Here, 4 detection systems (avidin-biotin complex, indirect immunofluorescence, peroxidase-labeled polymer conjugate, and the latter with Cyanine-3-Tyramide amplification) were compared using a beta-catenin antibody on a TMA containing a cohort of colorectal cancer specimens. Peroxidase-labeled polymer with or without tyramide enhancement was found to be the most sensitive method, revealing a greater staining intensity and percentage of nuclear staining, without an apparent increase in background. Subjective assessment of expression is highly dependent on the method of visualization and may illustrate why discrepant data is often seen in literature based on immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450422     DOI: 10.3816/CCC.2002.n.005

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  7 in total

1.  A novel method for preparation of tissue microarray.

Authors:  Han-Lei Dan; Ya-Li Zhang; Yan Zhang; Ya-Dong Wang; Zuo-Sheng Lai; Yu-Jie Yang; Hai-Hong Cui; Yan-Ting Jian; Jian Geng; Yan-Qing Ding; Chun-Hai Guo; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 2.  Wnt/β-catenin signalling in prostate cancer.

Authors:  Robert M Kypta; Jonathan Waxman
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

3.  Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Ewa Majdanik; Maria Chosia; Dariusz Bielicki; Jozef Kladny; Mariusz Kaczmarczyk; Krzysztof Safranow; Wenancjusz Domagala
Journal:  Virchows Arch       Date:  2009-05-15       Impact factor: 4.064

4.  Expression of p21WAF1 in Astler-Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Elzbieta Urasinska; Dariusz Bielicki; Krzysztof Safranow; Wenancjusz Domagala
Journal:  Virchows Arch       Date:  2011-03-03       Impact factor: 4.064

5.  Decentralized data sharing of tissue microarrays for investigative research in oncology.

Authors:  Wenjin Chen; Cristina Schmidt; Manish Parashar; Michael Reiss; David J Foran
Journal:  Cancer Inform       Date:  2007-06-06

6.  Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Dariusz Bielicki; Krzysztof Safranow; Wenancjusz Domagala
Journal:  Cell Oncol (Dordr)       Date:  2013-11-26       Impact factor: 6.730

7.  E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Dariusz Bielicki; Krzysztof Safranow; Wojciech Rogowski; Wenancjusz Domagala
Journal:  Pathol Oncol Res       Date:  2016-01-29       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.